January 27, 2025 Kigali, Rwanda and San Francisco, USA

Bio Usawa executives conducted site visits and potential partnership meetings in Southern California to learn more about the latest in ‘cutting-edge’ modular cleanroom systems. Modular technologies such as the one explored are critical for Bio Usawa’s mission to establish end-to-end “Biologics Good Manufacturing Plants on Demand” (“B-GMP on Demand”) in Africa and beyond.

Our commitment to excellence, visionary approach and extensive industry knowledge will empower us to shape the future of Africa’s biologics manufacturing and set new standards for country- and patient-centric, technologically advanced, and adaptable manufacturing facilities that will reinforce Africa’s collective defense against devastating diseases.

About Bio Usawa, Inc. (BUI) Bio Usawa has a singular mission: to manufacture high-quality, effective and affordable biosimilars for patients in Africa. We are applying our 100+ years of combined experience in the industry in partnership with governments, agencies, educators and health professionals to make transformative biomedicines in Africa, by Africans, for Africans and beyond. 

Click here to learn more about our company's recent successes and download our new White Paper on Regulatory Approaches to Biosimilars in Africa.